Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombosis resulting from heparin therapy

L L Gottschling1, C Alaniz

  • 1Department of Pharmacy, William Beaumont Hospital, Royal Oak, Michigan, USA.

Pharmacotherapy
|May 1, 1996
PubMed
Summary

Heparin can cause thrombocytopenia, a dangerous drop in platelets, which may paradoxically lead to thrombosis (blood clots). This case highlights the severe risks and diagnostic methods for this heparin complication.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conformational change in bacterio-opsin on binding to retinal.

Biophysical chemistry·1999
Same author

Pharmacologic management of adult idiopathic nephrotic syndrome.

Clinical pharmacy·1993
Same author

Calcium-channel blockers used in combination.

The Annals of pharmacotherapy·1992
Same author

The use of norfloxacin in a university hospital.

Hospital pharmacy·1991
Same author

Appropriate but not cost effective ceftazidime use in a university hospital.

Hospital pharmacy·1989
Same author

Management of cirrhotic ascites.

Clinical pharmacy·1989

Area of Science:

  • Pharmacology
  • Immunology
  • Vascular Medicine

Background:

  • Heparin is a common anticoagulant with a known risk of thrombocytopenia (low platelet count).
  • The paradoxical complication of thrombosis occurring in heparin-induced thrombocytopenia (HIT) is less recognized but carries significant morbidity and mortality.
  • Understanding the immune-mediated mechanisms of HIT is crucial for diagnosis and management.